Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares
AI-generated summary
Officer Eric Venker filed a Form 144 to propose the sale of 200,000 Common shares of Roivant Sciences Ltd. with an aggregate market value of $7,023,513.39. The sale will be executed through Rockefeller Financial LLC. The trades are planned under a Rule 10b5-1 trading plan adopted on 06/30/2026.
Key facts
- Seller
- Venker Eric
- Relationship
- Officer
- Shares to sell
- 200,000
- Market value
- $7,023,513.39
- Approximate sale date
- Oct 20, 2026
- Broker
- Rockefeller Financial LLC
- Acquired (1)
- Mar 24, 2025 · RSU Grant 019326 - Grant Date 04/20/2022
- Acquired (2)
- Apr 20, 2025 · RSU Grant 018861 - Grant Date 05/20/2021
- Acquired (3)
- May 20, 2025 · RSU Grant 020409 - Grant Date 07/26/2024
- Acquired (4)
- May 20, 2025 · RSU Grant 018861 - Grant Date 05/20/2021
- Acquired (5)
- Aug 20, 2025 · RSU Grant 020409 - Grant Date 07/26/2024
Rule 10b5-1 plan · adopted Jun 30, 2026
Remarks
- The shares reported on this Form 144 will be sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 06/30/2026.
More ROIV filings
- 4
Filed Nov 5, 2026
- SC 13G/A
Filed Nov 5, 2026
- 144
Filed Nov 3, 2026
- 4
Filed Oct 30, 2026
- 144
Filed Oct 28, 2026
- 4
Filed Oct 27, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.